AMN Healthcare (AMN) director adds 8,325 shares and receives 8,304 RSUs

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

AMN Healthcare Services director Sylvia Trent-Adams reported routine equity compensation changes. On May 1, 2026, 8,325 shares of common stock were acquired upon vesting and exercise of previously granted Restricted Stock Units (RSUs) under the AMN Healthcare 2017 Equity Plan, bringing her direct common stock holdings to 16,797 shares after the transaction. The filing also shows a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one future share of common stock. These new RSUs vest on the earlier of the one-year anniversary of the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders.

Insider Trade Summary

8,325 shares exercised/converted

Mixed 3 txns

Insider Trent-Adams Sylvia

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	8,325	$0.00	--
Grant/Award	Restricted Stock Units	8,304	$0.00	--
Exercise	Common Stock	8,325	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 16,797 shares (Direct, null)

Footnotes (1)

AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. RSUs do not have an expiration date. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027.

Key Figures

RSUs exercised into common stock: 8,325 shares Common shares held after transaction: 16,797 shares New RSU grant: 8,304 RSUs +2 more

5 metrics

RSUs exercised into common stock 8,325 shares Common stock acquired on May 1, 2026 from RSU vesting

Common shares held after transaction 16,797 shares Total direct AMN common stock following RSU vesting

New RSU grant 8,304 RSUs Granted May 1, 2026 under AMN Healthcare 2025 Equity Plan

Derivative exercises 1 exercise, 8,325 shares TransactionSummary exerciseCount and exerciseShares

RSU-to-share ratio 1 RSU : 1 share Each RSU represents a contingent right to one AMN common share

Key Terms

Restricted Stock Units, AMN Healthcare 2017 Equity Plan, AMN Healthcare 2025 Equity Plan, Annual Meeting of Shareholders

4 terms

Restricted Stock Units financial

"AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AMN Healthcare 2017 Equity Plan financial

"The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan."

AMN Healthcare 2025 Equity Plan financial

"The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan."

Annual Meeting of Shareholders financial

"vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 04:39 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Trent-Adams Sylvia

(Last)

(First)

(Middle)

C/O AMN HEALTHCARE SERVICES, INC.

12400 HIGH BLUFF DRIVE, SUITE 500

(Street)

SAN DIEGO

CALIFORNIA

92130

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		M⁽¹⁾		8,325	A	$0	16,797	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	05/01/2026		M			8,325	⁽³⁾	⁽⁴⁾	Common Stock	8,325	$0	0	D
Restricted Stock Units	⁽⁵⁾	05/01/2026		A		8,304		⁽⁶⁾	⁽⁴⁾	Common Stock	8,304	$0	8,304	D

Explanation of Responses:

1. AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

2. The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

3. The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

4. RSUs do not have an expiration date.

5. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

6. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027.

Remarks:

	/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Sylvia Trent-Adams	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did AMN (AMN) director Sylvia Trent-Adams report?

Director Sylvia Trent-Adams reported equity-related acquisitions. She acquired 8,325 shares of AMN common stock upon RSU vesting and received a new grant of 8,304 Restricted Stock Units. Both transactions are compensation-related, not open-market stock purchases or sales.

How many AMN (AMN) common shares does Sylvia Trent-Adams hold after these transactions?

After the reported transactions, Sylvia Trent-Adams directly holds 16,797 shares of AMN common stock. This reflects the addition of 8,325 vested RSU shares to her prior holdings, as disclosed in the Form 4 total shares following the transaction.

What are the terms of the new 8,304 RSUs granted to the AMN (AMN) director?

The new 8,304 RSUs were granted under the AMN Healthcare 2025 Equity Plan. Each RSU equals one share of common stock and vests on the earlier of one year from the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders.

Which AMN (AMN) equity plans govern Sylvia Trent-Adams’ RSU awards?

Two AMN Healthcare equity plans are involved. The 8,325 RSUs that vested into common stock came from the AMN Healthcare 2017 Equity Plan. The newly granted 8,304 RSUs are issued under the AMN Healthcare 2025 Equity Plan, each representing one future common share.

Were Sylvia Trent-Adams’ AMN (AMN) transactions open-market buys or sells?

No, the reported transactions are not open-market trades. They involve the exercise of 8,325 RSUs into common stock and a grant of 8,304 new RSUs as equity compensation. The filing shows no open-market purchases or sales of AMN shares.